Simultaneous determination of duloxetine and 4-hydroxy duloxetine glucuronide in human plasma and back-conversion study

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Marydele JO. The Merck Index: an encyclopedia of chemicals, drugs, and biologicals. 14th ed. Whitehouse Station Merck and Co. Inc, NJ, USA (2006).
  Google Scholar
• 2. Chalon SA, Granier LA, Vandenhende FR et al. Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study. Neuropsychopharmacology 28, 1685–1693 (2003).
  Medline CASGoogle Scholar
• 3. Stahl M, Lee-Zimmerman C, Cartwright S, Ann Morrissette D. Serotonergic drugs for depression and beyond. Curr. Drug Targets 14, 578–585 (2013).
  Medline CASGoogle Scholar
• 4. Bandelow B, Sher L, Bunevicius R et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int. J. Psychiatry. Clin. Pract. 16, 77–84 (2013).
  Google Scholar
• 5. Moser P. xPharm: The Comprehensive Pharmacology Reference. Elsevier (2008).
  Google Scholar
• 6. Sharma A, Goldberg MJ, Cerimele BJ. Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor. J. Clin. Pharmacol. 40, 161–167 (2000).
  Medline CASGoogle Scholar
• 7. Dhillion S. Duloxetine: a review of its use in the management of major depressive disorder in older adults. Drugs Aging 30, 59–79 (2013). •• Review of duloxetine.
  MedlineGoogle Scholar
• 8. Kaza M, Gilant E, Filist M, Szlaska I, Pawiński P, Rudzki PJ. Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine. Clin. Biochem. 47, 1313–1315 (2014). • Perform specificity of duloxetine in the presence of 4HDG in human plasma.
  Medline CASGoogle Scholar
• 9. Satonin DK, McCulloch JD, Kuo FJ, Knadler MP. Development and validation of a liquid chromatography-tandem mass spectrometric method for the determination of the major metabolites of duloxetine in human plasma. J. Chromatogr. B Biomed. Appl. Technol. Biomed. Life Sci. 852, 582–589 (2007). • First LC-MS/MS for quantification of 4HDG and 5-hydroxy-6-methoxy duloxetine sulfate in human plasma.
  Medline CASGoogle Scholar
• 10. Lantz RJ, Gillespie TA, Rash TJ et al. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. Drug Metab. Dispos. 31, 1142–1150 (2003).
  Medline CASGoogle Scholar
• 11. European Medicines Agency, Guideline on bioanalytical method validation, in: Committee for Medicinal Products for Human Use (2012). https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf
  Google Scholar
• 12. International Conference on Harmonization. Guideline M10 on bioanalytical method validation (step 2b) (2019). https://www.ema.europa.eu/en/documents/scientific-guideline/draft-ich-guideline-m10-bioanalytical-method-validation-step-2b_en.pdf
  Google Scholar
• 13. Mercolini L, Mandrioli R, Cazzolla R, Amore M, Raggi MA. HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure. J. Chromatogr. B Biomed. Appl. Technol. Biomed. Life Sci. 856, 81–87 (2007).
  Medline CASGoogle Scholar
• 14. Suh JH, Lee YY, Lee HJ et al. Dispersive liquid-liquid microextraction based on solidification of floating organic droplets followed by high performance liquid chromatography for the determination of duloxetine in human plasma. J. Pharm. Biomed. Anal. 75, 214–219 (2013).
  Medline CASGoogle Scholar
• 15. Li HF, Li T, Li Y, Shen YF. Pharmacokinetics and safety of duloxetine enteric-coated tablets in Chinese healthy volunteers: a randomized, open-label, single- and multiple-dose study. Clinc. Psychopharmacol. Neurosci. 11, 28–33 (2013).
  Medline CASGoogle Scholar
• 16. Ma N, Zhang BK, Li HD et al. Determination of duloxetine in human plasma via LC/MS and subsequent application to a pharmacokinetic study in healthy Chinese volunteers. Clin. Chim. Acta 380, 100–105 (2007).
  Medline CASGoogle Scholar
• 17. Selvan PS, Gowda KV, Mandal U, Solomon WDS, Pal TK. Determination of duloxetine in human plasma by liquid chromatography with atmospheric pressure ionization-tandem mass spectrometry and its application to pharmacokinetic study. J. Chromatogr. B Biomed. Appl. Technol. Biomed. Life Sci. 858, 269–275 (2007).
  Medline CASGoogle Scholar
• 18. Gajula R, Maddela R, Ravi VB, Inamadugu JK, Pilli NR. A rapid and sensitive liquid chromatography-tandem mass spectrometric assay for duloxetine in human plasma: its pharmacokinetic application. J. Pharm. Anal. 3, 36–44 (2013).
  MedlineGoogle Scholar
• 19. Techatanawat I, Bhuket PRN, Teerawonganan P et al. Bioequivalence study of duloxetine hydrochloride 60 mg EC capsules in the fasting and fed states in healthy Thai male volunteers. J. Health Res. 29, 165–169 (2015).
  Google Scholar
• 20. Chen XJ, Liang C, Cui LJ et al. A rapid LC-MS/MS method for simultaneous determination of quetiapine and duloxetine in rat plasma and its application to pharmacokinetic interaction study. J. Food Drug Anal. 27, 323–331 (2019).
  Medline CASGoogle Scholar
• 21. Rizea-Savu S, Duna SN, Ghita A, Lordachescu A, Chirila M. The effect of food on the single-dose bioavailability and tolerability of the highest marketed strength of duloxetine. Clin. Pharmacol. Drug Dev. 9, 797–804 (2020).
  Medline CASGoogle Scholar
• 22. Al-Shalabi R, Hefnawy M, Alrabiah H et al. Validated microemulsion liquid chromatography-fluorescence method for the quantification of duloxetine and its two main metabolites in plasma: application to clinical pharmacokinetic studies. Curr. Pharm. Anal. 15, 399–411 (2019). •• HPLC quantification of duloxetine and its two metabolites in rat plasma.
  CASGoogle Scholar
• 23. Briscoe C, Stiles MR, Hage DS. System suitability in bioanalytical LC/MS/MS. J. Pharm. Biomed. Anal. 44, 484–491 (2007).
  Medline CASGoogle Scholar
• 24. Loh GOK, Wong EYL, Tan YTF et al. Simple and rapid LC-MS/MS method for determination of sitagliptin in human plasma and application to bioequivalence study. J. Chromatogr. B Biomed. Appl. Technol. Biomed. Life Sci. 1159, 122337 (2020).
  Medline CASGoogle Scholar
• 25. Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food Drug Adm Cent Drug Eval Res (CDER), Cent Vet Met (2018). https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf
  Google Scholar
• 26. Algete P, Kancherla P, Boodida S, Albaseer SS. A fast and reliable LC-MS/MS method for simultaneous quantitation of fluoxetine and mirtazapine in human plasma. Anal. Methods 18, 7407–7414 (2014).
  Google Scholar
• 27. Banerjee S, Mazumdar S. Electrospray ionization mass spectrometry: a technique to access the information beyond the molecular weight of the analyte. Int. J. Anal. Chem. 2012, 1–40 (2012).
  Google Scholar
• 28. Crowley TE. High-performance liquid chromatography (Chapter 5). In: Purification and Characterization of Secondary Metabolites. Academic Press (2020).
  Google Scholar
• 29. Radel RJ, Sullivan JM, Hatfield JD. Catalytic oxidation of hydroquinone to quinone using molecular oxygen. Ind. Eng. Chem. Prod. Res. Dev. 21, 566–570 (1982).
  CASGoogle Scholar